Skip to main content

Harrow, Inc.

HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001360214

In the last 90 days, Harrow, Inc. insiders filed 0 open-market purchases and 1 sale; 223 institutions reported holding it in 13F filings for Q2 2026, worth $912.6M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding Harrow, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of HROW: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders8088+8
Shares15.4M16.2M+825.0K (+5.4%)
Value$103.5M$136.6M+$33.1M (+32.0%)

New holders (16)

Institutions that held Harrow, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to HROW in Q2 2022
InstitutionSharesValue% of portfolio
Private Capital Management, LLC996,351$7.25M1.15%
Acuitas Investments, LLC293,557$2.14M2.06%
Ameriprise Financial Inc105,338$767.0K0.00%
Equitable Trust Co55,965$407.0K0.03%
Jacobs Levy Equity Management, Inc43,545$317.0K0.00%
Marshall Wace, LLP25,969$189.0K0.00%
Qube Research & Technologies Ltd14,647$107.0K0.00%
Walleye Capital LLC14,760$107.0K0.00%
Jump Financial, LLC12,300$90.0K0.00%
Bank of Montreal10,750$79.0K0.00%
Cubist Systematic Strategies, LLC10,766$78.0K0.00%
Perritt Capital Management Inc10,440$76.0K0.05%
Captrust Financial Advisors7,000$51.0K0.00%
Stonehage Fleming Financial Services Holdings Ltd1,800$13.0K0.00%
Group One Trading, L.P.619$5.00K0.00%
Wells Fargo & Company163$1.00K0.00%

Sold out (8)

Institutions that held Harrow, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of HROW in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Precision Wealth Strategies, LLC50,158$342.0K
Man Group plc21,838$149.0K
Jane Street Group, LLC15,777$108.0K
Two Sigma Securities, LLC13,394$91.0K
PDT Partners, LLC12,186$83.0K
Principal Financial Group Inc10,469$71.0K
Envestnet Asset Management Inc10,209$70.0K
Goldman Sachs Group Inc10,141$69.0K